Welcome to our dedicated page for TD SYNNEX SEC filings (Ticker: SNX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on TD SYNNEX's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into TD SYNNEX's regulatory disclosures and financial reporting.
TD SYNNEX (SNX) reported an insider transaction by a director. On 11/03/2025, the reporting person sold 336 shares of common stock at $155.79 per share, executed under a Rule 10b5-1 trading plan adopted on August 2, 2025. Following the sale, the insider beneficially owns 7,330 shares directly.
TD SYNNEX (SNX) reported an insider transaction: a director sold a total of 5,000 shares of common stock on 11/03/2025 pursuant to a Rule 10b5-1 trading plan adopted on July 14, 2025.
The sales were executed in multiple trades at weighted average prices of $152.57, $153.44, $154.27, and $155.20, with underlying trade ranges disclosed in the footnotes. Following these transactions, the reporting person directly owns 57,515 shares.
SNX filed a Form 144 notice for a proposed sale under Rule 144. The filing lists 504 common shares to be sold with an aggregate market value of 78,870.96, through Morgan Stanley Smith Barney LLC, on the NYSE with an approximate sale date of 11/03/2025. The shares were acquired as Restricted Stock Awards on 05/31/2025.
Shares outstanding were 81,437,855 at the time of the notice; this is a baseline figure, not the amount being offered.
TD SYNNEX (SNX) reported an insider transaction by a company officer (President, Europe). On 10/31/2025, the officer sold 1,573 shares at $156.49 and 100 shares at $156.52.
After these trades, the officer directly owned 16,529 shares of common stock, as reflected in the Form 4. The filing lists these as open-market sales and confirms direct ownership status.
Form 144 filed for a planned sale of common stock. A holder filed notice to sell up to 1,673 shares of the issuer’s common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value $261,810.61. The shares are slated for sale on or about 10/31/2025 on the NYSE.
The shares were acquired as restricted stock from the issuer in two grants: 25 shares on 04/01/2025 and 1,648 shares on 10/15/2025. Shares outstanding were 81,437,855 as of the notice, which provides scale for the planned sale.
SNX: A holder filed a Form 144 notice to sell up to 62,764 shares of common stock. The shares are listed on the NYSE, with an approximate sale date of 10/30/2025. The filing lists Morgan Stanley Smith Barney LLC as broker. The aggregate market value for the proposed sale is $9,789,401.50, and 81,437,855 shares were outstanding.
The seller acquired 62,764 shares on 10/30/2025 via a stock option exercise paid in cash. In the prior three months, the Witt Family Trust reported sales of 861 shares on 09/17/2025 for $129,012.24, 861 shares on 08/18/2025 for $126,997.50, and 862 shares on 08/11/2025 for $126,188.18.
JPMorgan Chase & Co. filed an amended Schedule 13G reporting beneficial ownership of 3,851,860 shares of TD SYNNEX (SNX) common stock, representing 4.7% of the class, as of 09/30/2025.
The filing lists sole voting power over 3,551,633 shares, shared voting power of 0, sole dispositive power over 3,847,779 shares, and shared dispositive power over 4,007 shares. It is filed as a parent holding company (HC), with subsidiaries including J.P. Morgan Securities LLC and JPMorgan Chase Bank, National Association. JPMorgan certified the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.
TD SYNNEX (SNX) insider activity: The company’s Chief Human Resources Officer reported open‑market sales on 10/21/2025 totaling 1,762 shares of common stock. The sales were executed in several lots at prices between $154.50 and $154.81, each coded “S.” After these transactions, the reporting person beneficially owned 13,426 shares, held directly.
SNX: A stockholder filed a Form 144 to sell up to 1,762 shares of common stock on the NYSE through Morgan Stanley Smith Barney, reflecting an aggregate market value of $272,321.99, with an approximate sale date of 10/21/2025.
The seller’s recent acquisitions include 1,329 shares as restricted stock on 10/15/2025 and purchases via the employee stock purchase plan of 219 shares on 12/31/2024 and 214 shares on 06/30/2025. Shares outstanding were 81,437,855. In the past three months, a reported sale of 1,257 shares generated gross proceeds of $179,015.53.
TD SYNNEX (SNX) director reported open-market sales of common stock on 10/16/2025 under a Rule 10b5-1 trading plan adopted on July 14, 2025. The transactions comprised 3,213 shares at a weighted average price of $155.64 and 1,787 shares at a weighted average price of $156.37. Following these trades, the reporting person directly beneficially owns 62,515 shares. The weighted averages reflect multiple executions within disclosed price ranges.